Curkovic, I., Rentsch, K., Frei, P., Fried, M., Rogler, G., Kullak-Ublick, G., & Jetter, A. (2013). Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations. European Journal of Clinical Pharmacology, 69(8), 1521. https://doi.org/10.1007/s00228-013-1500-1
Chicago Style (17th ed.) CitationCurkovic, Ivanka, Katharina Rentsch, Pascal Frei, Michael Fried, Gerhard Rogler, Gerd Kullak-Ublick, and Alexander Jetter. "Low Allopurinol Doses Are Sufficient to Optimize Azathioprine Therapy in Inflammatory Bowel Disease Patients with Inadequate Thiopurine Metabolite Concentrations." European Journal of Clinical Pharmacology 69, no. 8 (2013): 1521. https://doi.org/10.1007/s00228-013-1500-1.
MLA (9th ed.) CitationCurkovic, Ivanka, et al. "Low Allopurinol Doses Are Sufficient to Optimize Azathioprine Therapy in Inflammatory Bowel Disease Patients with Inadequate Thiopurine Metabolite Concentrations." European Journal of Clinical Pharmacology, vol. 69, no. 8, 2013, p. 1521, https://doi.org/10.1007/s00228-013-1500-1.